Angelini Pharma
    • Who we are
    • Vision, purpose & values
    • Production Plants
    • People
      • Leadership Team
    • Key Financials
    • Brain Health
      • Mental Health
      • Epilepsy
    • Specialty and Primary care
    • Consumer Health
    • Science & Innovation
    • Clinical Trials
    • Research collaborations
    • Independent Research (IIT/RIS)
    • Licensing Out
    • Sustainability
    • Diversity & Inclusion
    • Ethics
    • Transparency
    • Quality and EHS
    • News
    • Press releases
    • Media Resources
  • Career
    • Austria
    • Bulgaria
    • Czech Republic
    • France
    • Germany
    • Greece
    • Hungary
    • Italy
    • Nordics
    • Poland
    • Portugal
    • Romania
    • Russia
    • Slovakia
    • Spain
    • Switzerland
    • Turkey
    • United Kingdom
    • United States
  1. Angelini Pharma
  2. Our responsibility
  3. Transparency
  4. Netherlands

Netherlands

Angelini Pharma France SAS has fulfilled reporting obligations per local requirements. Disclosures are available on the Foundation for the Code for Pharmaceutical Advertising (CGR) website: Stichting Transparantieregister Zorg - Home. Inquiries may be submitted to quality_netherlands@angelinipharma.com.

 

2021

Netherlands - Transparency Report

  • Privacy
  • Cookie Policy
  • Terms of use
  • Accessibility declaration
  • Webscraping
  • Transparency
  • Contact
  • Site map
  • Credits
  • Cookie settings
  • Top Employer Europe 2025
  • X
  • Linkedin
  • Instagram

Angelini Pharma S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2025 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Back to top